Phosphoglycerate dehydrogenase is a novel predictor for poor prognosis in gastric cancer
Main Authors: | Xian, Yun, Zhang, Shu, Wang, Xudong, Qin, Jin, Wang, Wei, Wu, Han |
---|---|
Format: | Online |
Language: | English |
Published: |
Dove Medical Press
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019466/ |
Similar Items
-
Phosphoglycerate dehydrogenase is dispensable for breast tumor maintenance and growth
by: Chen, Jinyun, et al.
Published: (2013) -
A novel small-molecule inhibitor of 3-phosphoglycerate dehydrogenase
by: Mullarky, Edouard, et al.
Published: (2016) -
Phosphoglycerate kinase-1 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancer
by: Sun, S, et al.
Published: (2015) -
Down-Regulated Phosphoglycerate Kinase 1 Expression Is Associated With Poor Prognosis in Patients With Gallbladder Cancer
by: Lu, Wei, et al.
Published: (2015) -
Amplification of phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
by: Locasale, Jason W, et al.
Published: (2012)